5991-03-7

Basic information

• Product Name: 1,6-anhydro-4-O-methyl-2-O-p-toluenesulphonyl-β-D-glucopyranose
• CAS NO: 5991-03-7
• Molecular Weight: 330.359
• Mol File: 5991-03-7.mol

Chemical Properties

• CAS DataBase Reference: 1,6-anhydro-4-O-methyl-2-O-p-toluenesulphonyl-β-D-glucopyranose(CAS DataBase Reference)
• NIST Chemistry Reference: 1,6-anhydro-4-O-methyl-2-O-p-toluenesulphonyl-β-D-glucopyranose(5991-03-7)
• EPA Substance Registry System: 1,6-anhydro-4-O-methyl-2-O-p-toluenesulphonyl-β-D-glucopyranose(5991-03-7)

Safety Data

• Hazardous Substances Data: 5991-03-7(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 6167-32-4 1,6:3,4-dianhydro-2-O-tosyl-D-galactose 

Downstream Products

• 156660-36-5 3-benzyl-(1,6-anhydro-2,3-dideoxy-4-O-methyl-β-D-mannopyrano)-<2,3-d>-2-oxazolidinone 
• 156660-37-6 1,6-anhydro-2-benzylamino-2-deoxy-4-O-methyl-β-D-mannopyranose 
• 241129-86-2 (2R,3S,4S,5R,6R)-5-Acetoxy-3-((2R,3R,4R,5S,6R)-6-acetoxymethyl-3-azido-4-benzyloxy-5-methoxy-tetrahydro-pyran-2-yloxy)-4-benzyloxy-6-[2-(9H-fluoren-9-ylmethoxycarbonylamino)-ethoxy]-tetrahydro-pyran-2-carboxylic acid methyl ester 
• 241129-80-6 (2R,3S,4S,5R,6R)-5-Acetoxy-3-((2R,3R,4R,5S,6R)-6-acetoxymethyl-3-azido-4-benzyloxy-5-methoxy-tetrahydro-pyran-2-yloxy)-6-(2-amino-ethoxy)-4-benzyloxy-tetrahydro-pyran-2-carboxylic acid methyl ester 
• 241129-78-2 6-O-acetyl-2-azido-3-O-benzyl-2-deoxy-4-O-methyl-1-O-trichloroacetimidoyl-D-glucopyranose 
• 174911-12-7 1,6-anhydro-2-azido-3-O-benzyl-2-deoxy-4-O-methyl-β-D-glucopyranose 
• 156660-35-4 1,6-anhydro-3-O-(N-benzylcarbamoyl)-4-O-methyl-2-O-toluene-p-sulfonyl-β-D-glucopyranose 
• 88159-88-0 1,6-anhydro-4-O-methyl-2-O-p-toluenesulphonyl-3-O-trimethylsilyl-β-D-glucopyranose 

Relevant articles and documents

Synthesis and biological activity of oligomer-model compounds containing units of a key platelet-binding disaccharide of heparin

A key disaccharide unit in heparin, O-(2-deoxy-2-sulfamido-6-O-sulfo-α-D-glucopyranosyl)-(1→4)-2-O-sulfo-α-L-idop yranosyluronic acid, was previously found to be responsible for the binding interaction of heparin to platelets. A clustering effect to enhance the binding was found to be dependent on the number and frequency of the disaccharide units in a heparin molecule. To systematically examine the clustering effect, three oligomer-model compounds containing two or three units of the disaccharide were synthesized. These compounds inhibited 3H-labelled heparin binding to human platelets more strongly than a compound containing only one unit of the disaccharide.